ROTEF-D Tablets

ROTEF-D Tablets

ROTEF-D Tablets contain Drotaverine Hydrochloride 80 mg and Mefenamic Acid 250 mg in a film-coated tablet formulation. Available in 10×10 blister packing, the product should be used under professional medical guidance.

ROTEF-D Tablets contain a combination of Drotaverine Hydrochloride 80 mg and Mefenamic Acid 250 mg in a film-coated tablet formulation. The product is supplied in 10×10 blister packing and is intended for use as directed by a qualified healthcare professional.

Key Highlights

  • Drotaverine Hydrochloride 80 mg + Mefenamic Acid 250 mg
  • Film-coated tablet formulation
  • 10 × 10 blister packing
  • Combination pharmaceutical formulation
  • Prescription medicine
  • Use as directed by a qualified healthcare professional
Business Guide*
close slider
Scroll to Top